Low Signal

Stereotactic Body Radiotherapy

Stereotactic Body Radiotherapy is flagged as low signal because public records show operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.

Program overview

Context

Indication: Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8

Mechanism: Unknown

Modality: Unknown

Sponsor: NRG Oncology

Scores

Risk-signal summary

Registry: 0/5

Timeline: 0/5

Recruitment burden: 2/5

Results availability: 0/5

Program risk: 1/5

Evidence

Public links

https://clinicaltrials.gov/study/NCT02364557

Linked trials

Trial-level signal details

TrialStatusTimelineResultsBurden
NCT02364557Low Signal (COMPLETED)NoneLow Signalrare_population_signal | complex_intervention_signal